Fact sheets

General

 Antigenics company overview (150 K)

 The Antigenics approach to cancer vaccines (50 K)

Heat shock proteins

 Introduction to heat shock protein technology (35 K)

 Heat shock proteins: How they work (145 K)

 White paper: “Heat Shock Proteins’ Vaccine Potential” (85 K)

Products

 Introduction to Oncophage (41 K)

 Introduction to AG-707 (40 K)

 Introduction to QS-21 (49 K)

 White paper: “Advent of the Adjuvant: QS-21 Makes Vaccines Look Good” (97 K)

Disease areas

 Kidney cancer at a glance (98 K)

 Melanoma at a glance (79 K)

 Chronic myelogenous leukemia (CML) at a glance (102 K)

 Genital herpes at a glance (39 K)